Vanguard Group
VIVS

Vanguard Group’s VivoSim Labs VIVS Stock Holding History

Vanguard Group’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$40.5K Hold
22,374
– – ﹤0.01% 4266
2025
Q3 		$65.3K Hold
22,374
– – ﹤0.01% 4265
2025
Q2 		$32.9K Hold
22,374
– – ﹤0.01% 4221
2025
Q1 		$50.1K Buy
22,374
+12,821
+134% +$62.7K ﹤0.01% 4192
2024
Q4 		$52.7K Sell
9,553
-19,404
-67% -$98.3K ﹤0.01% 4210
2024
Q3 		$177K Sell
28,957
-511
-2% -$3.56K ﹤0.01% 4152
2024
Q2 		$269K Hold
29,468
– – ﹤0.01% 4119
2024
Q1 		$364K Hold
29,468
– – ﹤0.01% 4080
2023
Q4 		$393K Buy
29,468
+6,149
+26% +$91.3K ﹤0.01% 4102
2023
Q3 		$350K Sell
23,319
-283
-1% -$5K ﹤0.01% 4154
2023
Q2 		$479K Hold
23,602
– – ﹤0.01% 4130
2023
Q1 		$620K Hold
23,602
– – ﹤0.01% 4059
2022
Q4 		$399K Buy
23,602
+12
+0.1% +$240 ﹤0.01% 4160
2022
Q3 		$580K Buy
23,590
+1,097
+5% +$35K ﹤0.01% 4173
2022
Q2 		$478K Hold
22,493
– – ﹤0.01% 4306
2022
Q1 		$1.01M Sell
22,493
-6,317
-22% -$263K ﹤0.01% 4205
2021
Q4 		$1.25M Sell
28,810
-934
-3% -$60.1K ﹤0.01% 4199
2021
Q3 		$2.43M Buy
29,744
+186
+0.6% +$17K ﹤0.01% 3999
2021
Q2 		$3.33M Buy
29,558
+8,409
+40% +$845K ﹤0.01% 3793
2021
Q1 		$2.45M Buy
21,149
+3,187
+18% +$498K ﹤0.01% 3821
2020
Q4 		$2.65M Buy
17,962
+771
+4% +$87.8K ﹤0.01% 3588
2020
Q3 		$1.63M Sell
17,191
-1,272
-7% -$164K ﹤0.01% 3541
2020
Q2 		$2.44M Buy
18,463
+443
+2% +$54K ﹤0.01% 3378
2020
Q1 		$1.77M Hold
18,020
– – ﹤0.01% 3341
2019
Q4 		$1.54M Buy
18,020
+3
+0% +$281 ﹤0.01% 3520
2019
Q3 		$1.13M Sell
18,017
-1,312
-7% -$110K ﹤0.01% 3621
2019
Q2 		$2.43M Sell
19,329
-1,135
-6% -$215K ﹤0.01% 3416
2019
Q1 		$4.87M Buy
20,464
+505
+3% +$127K ﹤0.01% 3153
2018
Q4 		$4.58M Buy
19,959
+78
+0.4% +$19.6K ﹤0.01% 3116
2018
Q3 		$5.49M Buy
19,881
+216
+1% +$65K ﹤0.01% 3198
2018
Q2 		$6.61M Buy
19,665
+738
+4% +$243K ﹤0.01% 3100
2018
Q1 		$4.68M Sell
18,927
-35
-0.2% -$10.2K ﹤0.01% 3178
2017
Q4 		$6.1M Sell
18,962
-21
-0.1% -$7.81K ﹤0.01% 3047
2017
Q3 		$10.1M Buy
18,983
+357
+2% +$190K ﹤0.01% 2799
2017
Q2 		$11.8M Buy
18,626
+918
+5% +$617K ﹤0.01% 2697
2017
Q1 		$13.5M Buy
17,708
+1,387
+8% +$1.1M ﹤0.01% 2620
2016
Q4 		$13.3M Buy
16,321
+1,948
+14% +$1.55M ﹤0.01% 2611
2016
Q3 		$13.1M Buy
14,373
+304
+2% +$298K ﹤0.01% 2559
2016
Q2 		$12.6M Buy
14,069
+1,172
+9% +$786K ﹤0.01% 2539
2016
Q1 		$6.72M Sell
12,897
-332
-3% -$169K ﹤0.01% 2814
2015
Q4 		$7.91M Buy
13,229
+452
+4% +$328K ﹤0.01% 2764
2015
Q3 		$8.22M Buy
12,777
+1,478
+13% +$1.12M ﹤0.01% 2703
2015
Q2 		$10.2M Buy
11,299
+1,137
+11% +$1.27M ﹤0.01% 2659
2015
Q1 		$8.63M Buy
10,162
+771
+8% +$1.06M ﹤0.01% 2715
2014
Q4 		$16.3M Buy
9,391
+1,532
+19% +$2.35M ﹤0.01% 2322
2014
Q3 		$12M Buy
7,859
+136
+2% +$247K ﹤0.01% 2412
2014
Q2 		$15.5M Buy
7,723
+430
+6% +$721K ﹤0.01% 2309
2014
Q1 		$13.4M Buy
7,293
+901
+14% +$2.09M ﹤0.01% 2358
2013
Q4 		$17M Buy
6,392
+2,107
+49% +$4.14M ﹤0.01% 2227
2013
Q3 		$5.93M Buy
+4,285
New +$5.98M ﹤0.01% 2647

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

Vanguard Group's VIVS Position: Q4 2025 in Review

Vanguard Group held its VivoSim Labs (VIVS) position steady in Q4 2025 at 22,374 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4266.

Vanguard Group first reported a position in VIVS in Q3 2013 and has held it in 50 quarters since. The position peaked at $17M in Q4 2013. 27 funds tracked by Wall St. Rank hold VIVS as of Q4 2025.

  • Vanguard Group held 22,374 shares of VivoSim Labs worth $40.5K as of Q4 2025.
  • Vanguard Group left its VivoSim Labs share count unchanged in Q4 2025.
  • VivoSim Labs made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4266 holding.
  • Vanguard Group first reported a position in VivoSim Labs in Q3 2013 and has held it in 50 quarters since.
  • Vanguard Group's VivoSim Labs position peaked at $17M in Q4 2013.
  • 27 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.